Key result
Angiographically significant non-culprit lesions in acute coronary syndrome had a higher plaque burden but similar maximum lipid core burden index compared to non-stenotic lesions (308.1 vs 287.8, p=0.67).
Why the study?
ACS patients have high event rates related to non-culprit lesions, but differences in high-risk plaque characteristics between significant versus non-stenotic non-culprit lesions and comparisons with chronic coronary syndrome were unclear.
Do angiographically significant non-culprit plaques have more high-risk characteristics compared to non-stenotic plaques in patients with acute coronary syndrome?
Observational (n=63)
Yes
Do angiographically significant non-culprit plaques have more high-risk characteristics compared to non-stenotic plaques in patients with acute coronary syndrome?
Absolute Event Rate: 308.1% vs 287.8%
p-value: p=0.67
Although angiographically significant non-culprit lesions in ACS have a higher plaque burden, they do not demonstrate significantly higher lipid content (maxLCBI 4mm) compared to non-stenotic lesions.
Suggests angiographic stenosis does not identify higher-lipid non-culprit plaques in ACS; leaves open optimal vulnerability metrics beyond burden.
Patients with acute coronary syndrome (ACS) have high event rates related to non-culprit (NC) lesions, therefore plaque composition of these lesions is of great interest. Although marginal atherosclerotic lesions were studied extensively, more significant lesions might have more high-risk characteristics. To compare differences in high-risk lesion characteristics between significant versus non-stenotic NC plaques in ACS and the discrepancies with chronic coronary syndrome (CCS) patients. Non-culprit vessels of 26 ACS patients with 26 angiographically significant lesions and 37 patients (17 ACS and 20 CCS) with 48 non-stenotic lesions were investigated with intravascular ultrasound (IVUS) and near-infrared spectroscopy (NIRS). Overall, 74 segments of 30 mm length were analyzed in 1 mm intervals. External elastic lamina (EEM), plaque burden (PB), minimal luminal area (MLA), percent atheroma volume (PAV) and lipid core burden index maximum 4 mm (maxLCBI 4mm ) were determined for each segment. Cardiovascular risk factors were similar in all groups. PB was higher and MLA smaller in significant non-culprit ACS lesions vs non-stenotic lesions: PB 73.5% (IQR 68.7–78.5) vs 59.2 (IQR 49.6–71.5), p = 0.003, MLA 3.0 mm 2 (IQR 2.3–3.9) vs 4.0 mm 2 (IQR 2.8–4.7). MaxLCBI 4mm was similar 308.1 (±155.4) vs 287.8 (±165.7), p = 0.67. Among non-stenotic plaques, MaxLCBI 4mm was comparable between ACS and CCS patients, 275.7 (±151.5) in CCS patients vs 287.8 (±165.7) in ACS patients, p = 0.79. Although visually significant non-culprit lesions had a higher plaque burden compared to non-stenotic lesions, a significant relation between MaxLCBI 4mm and hemodynamic significance of the plaques couldn’t be established. • Intravascular ultrasound (IVUS) is helpful to show features of non-culprit lesions responsible for unanticipated events. • Lipid content of coronary plaques is measured by NIRS and represented by the lipid core burden index (LCBI) • Combination of plaques with high lipid content (MaxLCBI 4mm >400) and large plaque burden >70% were key features of vulnerable plaques that placed patients at especially substantial risk for future MACE.
No takes yet. Share an insight, caveat, or question.
Morsy et al. (2024) conducted an observational in Acute coronary syndrome and chronic coronary syndrome (n=63). Angiographically significant non-culprit lesions (diameter stenoses ≥70%) vs. Non-stenotic non-culprit lesions (diameter stenoses <70%) was evaluated on Maximum lipid core burden index within 4 mm (MaxLCBI4mm) (p=0.67). Angiographically significant non-culprit lesions in acute coronary syndrome had a higher plaque burden but similar maximum lipid core burden index compared to non-stenotic lesions (308.1 vs 287.8, p=0.67).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: